DK0379367T3 - Fremgangsmåde til behandling eller forebyggelse af intrinsisk ældet hud med retinoider - Google Patents

Fremgangsmåde til behandling eller forebyggelse af intrinsisk ældet hud med retinoider

Info

Publication number
DK0379367T3
DK0379367T3 DK90300521T DK90300521T DK0379367T3 DK 0379367 T3 DK0379367 T3 DK 0379367T3 DK 90300521 T DK90300521 T DK 90300521T DK 90300521 T DK90300521 T DK 90300521T DK 0379367 T3 DK0379367 T3 DK 0379367T3
Authority
DK
Denmark
Prior art keywords
retinoids
treating
preventing
aged skin
intrinsically aged
Prior art date
Application number
DK90300521T
Other languages
English (en)
Inventor
James A Mezick
Albert M Kligman
Robert J Capetola
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25672393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0379367(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CA000588835A external-priority patent/CA1335651C/en
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of DK0379367T3 publication Critical patent/DK0379367T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Vapour Deposition (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
DK90300521T 1989-01-19 1990-01-18 Fremgangsmåde til behandling eller forebyggelse af intrinsisk ældet hud med retinoider DK0379367T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29911989A 1989-01-19 1989-01-19
CA000588835A CA1335651C (en) 1989-01-20 1989-01-20 Method for the treatment or prevention of intrinsically aged skin with retinoids

Publications (1)

Publication Number Publication Date
DK0379367T3 true DK0379367T3 (da) 1998-10-19

Family

ID=25672393

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90300521T DK0379367T3 (da) 1989-01-19 1990-01-18 Fremgangsmåde til behandling eller forebyggelse af intrinsisk ældet hud med retinoider

Country Status (15)

Country Link
EP (2) EP0379367B1 (da)
JP (1) JP2931349B2 (da)
AT (1) ATE164513T1 (da)
AU (1) AU636595B2 (da)
DE (1) DE69032182T2 (da)
DK (1) DK0379367T3 (da)
ES (1) ES2115590T3 (da)
FI (1) FI114968B (da)
GR (1) GR3026573T3 (da)
IL (1) IL93106A0 (da)
MY (1) MY106263A (da)
NO (1) NO900251L (da)
PH (1) PH27578A (da)
PT (1) PT92905B (da)
SG (1) SG73394A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
FR2674127B1 (fr) * 1991-03-20 1993-06-11 Oreal Composition cosmetique pour lutter contre le vieillissement de la peau contenant en association au moins un retinouide et au moins une dialkyl- ou trialkylxanthine.
DE69503368D1 (de) 1994-04-12 1998-08-13 Kao Corp Dermatologisches präparat
WO1996029069A1 (en) * 1995-03-20 1996-09-26 Allergan Use of retinoids for the manufacture of a medicament for the treatment of restenosis
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
JP2002515898A (ja) 1997-02-25 2002-05-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ヒトの皮膚での経時老化を防止および治療するための方法および組成物
EP0992232A4 (en) * 1997-03-11 2003-01-02 Pola Chem Ind Inc TESTING METHODS OF SKIN CARE AGENTS AND EXTERNAL SKIN CARE PRODUCTS MANUFACTURING METHOD
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
USH2043H1 (en) 1997-05-23 2002-08-06 The Procter & Gamble Company Skin care compositions
DE19806946A1 (de) * 1998-02-19 1999-09-09 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
DE19820392A1 (de) * 1998-05-07 1999-11-11 Beiersdorf Ag Wirkstoffkombinationen enthaltende Hautpflegemittel
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
JP2002047125A (ja) * 2000-05-26 2002-02-12 Shiseido Co Ltd 皮脂分泌抑制用皮膚外用剤
JP2002284678A (ja) * 2001-03-23 2002-10-03 Ajinomoto Co Inc 皮膚外用剤
US20050202055A1 (en) * 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
BRPI0620811A2 (pt) 2005-12-30 2011-11-22 Revance Therapeutics Inc heterÈmeros de arginina para administração tópica
ES2430204T3 (es) 2006-08-16 2013-11-19 AmDerma Pharmaceuticals, LLC Uso de compuestos de 2,5-dihidroxibenceno y sus derivados para el tratamiento de la rosácea
JP5665276B2 (ja) 2008-02-27 2015-02-04 花王株式会社 皮膚老化予防又は改善剤
EP2133066A1 (en) 2008-06-13 2009-12-16 Antonio Puig, S.A. Cosmetic and dermatological composition containing a mixture of retinol derivatives and tocotrienols.
KR101709489B1 (ko) 2008-12-22 2017-02-23 존슨 앤드 존슨 컨슈머 홀딩스 프랑스 레티노이드를 포함하는 조성물 및 피부 상태를 처리하는 방법
US11707442B2 (en) 2015-09-25 2023-07-25 The General Hospital Corporation Antibacterial and antifungal compounds
SG11201806628UA (en) * 2016-02-03 2018-09-27 Galderma Res & Dev New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
US10980725B2 (en) 2017-09-28 2021-04-20 Johnson & Johnson Consumer Inc. Cosmetic compositions and method of treating the skin
GB2642547A (en) * 2024-07-12 2026-01-14 Univ Durham Compounds for use in senotherapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1466062A (en) * 1974-04-09 1977-03-02 Knight K Cosmetic preparations
FR2479819A1 (fr) * 1980-04-04 1981-10-09 Fabre Sa Pierre Le retinoate de zinc, sa preparation et les compositions topiques le contenant
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
JPS62502546A (ja) * 1985-04-22 1987-10-01 エイボン　プロダクツ　インコ−ポレイテツド しわを減少させる組成物及び方法
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
FI881217A0 (fi) * 1986-07-16 1988-03-15 Albert M Kligman Foerfaranden foer vaordande av av solen skadad maenniskohud medelst retinoider.
ZA879063B (en) * 1986-12-22 1989-04-26 Hoffmann La Roche Use of 13-cis retinoic acid
FR2612775B1 (fr) * 1987-03-25 1991-10-11 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
WO1988007857A1 (en) * 1987-04-06 1988-10-20 Daltex Medical Sciences, Inc. Treatment of aged skin with oral 13-cis-retinoic acid

Also Published As

Publication number Publication date
GR3026573T3 (en) 1998-07-31
MY106263A (en) 1995-04-29
SG73394A1 (en) 2000-06-20
NO900251D0 (no) 1990-01-18
EP0379367A2 (en) 1990-07-25
AU636595B2 (en) 1993-05-06
FI900293A0 (fi) 1990-01-18
NO900251L (no) 1990-07-20
ES2115590T3 (es) 1998-07-01
DE69032182T2 (de) 1998-08-20
EP0379367A3 (en) 1991-04-24
PH27578A (en) 1993-08-18
PT92905B (pt) 1995-12-29
JPH02288822A (ja) 1990-11-28
FI114968B (fi) 2005-02-15
IL93106A0 (en) 1990-11-05
JP2931349B2 (ja) 1999-08-09
AU4857390A (en) 1990-07-26
PT92905A (pt) 1990-07-31
EP0379367B1 (en) 1998-04-01
DE69032182D1 (de) 1998-05-07
EP0815840A3 (en) 1998-03-04
ATE164513T1 (de) 1998-04-15
EP0815840A2 (en) 1998-01-07

Similar Documents

Publication Publication Date Title
AU636595B2 (en) Method for the treatment or prevention of intrinsically aged skin with retinoids
AU4876190A (en) Compositions and method for the treatment of periodontal disease
EP0929870A4 (en) SYSTEM AND METHOD FOR THE EXTRACTION AND CODING OF MEDICAL SPECIFIC LANGUAGE
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
CA2288706A1 (en) Use of high dose retinoids for the treatment of skin disorders
DK0533667T3 (da) Fremgangsmåde til behandling af ældnings- eller fotobeskadiget hud
ATE197763T1 (de) Zusammensetzungen, welche ein rar alpha spezifischer liganden und mindestens eine fettsäure enthalten
BR8802305A (pt) Processo para estabilizar uma solucao de tetracloreto de vanadio e aperfeicoamento em um processo continuo para polimerizar uma ou mais olefinas,em um solvente organico inerte,usando um composto de vanadio como catalisador
NO881051D0 (no) Metoder for behandling av solskadet, human hud med retinoider.
Thayer The effect of facial expression sequence upon judgments of emotion
EP0803247A3 (en) Skin care compositions containing a retinoid
ATE67676T1 (de) Medikamentoese behandlungen.
IE873478L (en) Use of 13-cis retinoic acid
IT1228067B (it) Procedimento e dispositivo per il mantenimento di un processo di degassificazione a ritroso in un estrusore monococlea.
BR8101117A (pt) Aparelho de controle de sinais, aparelho monitor, processo para controlar um sinal e processo para supervisionar automaticamente a ocorrencia de uma pluralidade de eventos em um processo ciclico
DE3872435D1 (de) Verfahren zur herstellung von 2.3-dimethylbuten-1 aus propen.
EP0349182A3 (en) Method and apparatus for approximating polygonal line to curve
DE69008293D1 (de) Synergistisches Mittel zur Hautdepigmentierung.
BR8807578A (pt) Aparelho e processo para processamento de concentrado de suco,de suco citrico e para aumentar o nivel brix dos mesmos
Kusumi Similarity between constituent words or phrases of metaphors: Effects of feature salience in comprehending metaphor.
BR9201681A (pt) Mitogenio,medicamento,metodo de tratamento,e processo para preparar tal mitogenio
CA2012208A1 (en) Method of treating periodontitis
Rindos et al. Analysis of the preemptive resume policy with nonzero overhead
BR8504201A (pt) Processo e dispositivo para medicao de alongamento da chapa em laminacao
TW326510B (en) Recognition method and apparatus for Chinese phonogram